American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

special video edition

April 02, 2013

Newsletter Sponsor

Interview with Lonza at Informex 2013

While Lonza Custom Manufacturing will continue to focus on its core areas of expertise, including small molecule APIs and peptides, the company is honing in on ADCs, highly potent APIs and cytotoxics. Catherine Hanley, pharma and biotech marketing manager, discusses Lonza’s ability to seamlessly execute services in these niche technology areas.

Newsletter Sponsor

Interview with SCYNEXIS at Informex 2013

Clare Murray, Ph.D., Business Development Director at SCYNEXIS, discusses the CRO’s offerings from early discovery research through API manufacture. Integrated pharmaceutical solutions that focus on process chemistry and analytical support are also addressed. Learn more about SCYNEXIS capabilities that help confront challenges in drug development, from beginning to end.

	Featured Videos

Turning R&D into True Innovation
Turning R&D into True Innovation
R&D is innovative by definition. True innovation is employing experts and empowering them to challenge the way R&D is done. It's not just creating new technologies or improving existing products, it's... read more »

Avoid Unblinding Risks when Defining Drug Supply Strategy in an IRT System
Avoid Unblinding Risks when Defining Drug Supply Strategy in an IRT System
Cenduit’s IRT platform utilizes sophisticated drug supply algorithms that determine when to send study materials to the investigative site and that accommodate any changes in drug supply strategy that... read more »

Protecting Your Brand
Protecting Your Brand
A true partner is someone who cares about your interests just as much as you do. At Ei, we make exceptional effort to protect your brand from the first time we meet to the time a customer interacts ... read more »

Optimizing Efficiencies between the Sponsor, IXRS® and Drug Packaging/ Distribution Vendors
Optimizing Efficiencies between the Sponsor, IXRS® and Drug Packaging/ Distribution Vendors
As a global leader with the experience of conducting over 1900 clinical trials worldwide, Almac helps pharmaceutical and biotech companies speed the process of getting new drugs to market by ... read more »

Coming to America: Regulatory Strategies for Foreign Drug and Device Companies
Coming to America: Regulatory Strategies for Foreign Drug and Device Companies
U.S. regulatory affairs expert Brian Bollwage is currently the vice president of global regulatory affairs at Theorem Clinical Research and he has also served in the role of regulatory counsel at i3 ... read more »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA